Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL
Clinical trial NCT04155710 · COMPLETED
Trial details
- NCT number
- NCT04155710
- Sponsor
- Iovance Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-19
- Primary completion
- 2024-11-11
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.